ACH-000143 is a potent and orally active melatonin receptor agonist, with EC50 values of 0.06 nM and 0.32 nM for MT1 and MT2, respectively.
IC50&Target
MT1
0.06 nM (EC50)
MT2
0.32 nM (EC50)
体内研究
ACH-000143 reduces liver triglycerides and steatosis in diet-Induced obese rats.
ACH-000143 is devoid of hERG binding, genotoxicity, and behavioral alterations at doses up to 100 mg/kg p.o., supporting further investigation of this compound as a drug candidate.
ACH-000143 significantly reduces plasma glucose at 10 mg/kg (−16.4%, p < 0.05) and 30 mg/kg (−16.9%, p < 0.01).
Animal Model:
High-fat diet rats.
Dosage:
10 and 30 mg/kg.
Administration:
Orally, once daily for two months.
Result:
Significantly reduced the weekly BW gain on weeks.
分子式
C13H16ClN3O3
分子量
297.74
CAS号
2225836-30-4
运输条件
Room temperature in continental US; may vary elsewhere.